Velocity, Privia Health Partner to Embed Clinical Research

Multi-specialty clinical sites organization Velocity Clinical Research, and Privia Health, a physician enablement company, have partnered to embed clinical research sites in Privia’s practice network.¹

The partnership will integrate research sites within existing Privia Care Center locations that do not currently conduct clinical trials. Privia serves more than 3,700 providers and 4.4 million patients. Velocity will staff and operate the joint research sites, bringing management experience in clinical trial operations and patient recruitment. The first of these sites is in West Texas Health, a clinic in Abilene, Texas.

This latest partnership builds on Velocity’s December 2022 acquisition of Meridian Clinical Research, which accelerated its move into specialty care. The acquisition provided approximately 80 sites in the U.S. and Europe, and a tech hub in Hyderabad, India.²

Paul Evans, PhD, Velocity President and CEO, said in a release: “Through an embedded model, Privia benefits from increased activity at their clinics and Velocity has the opportunity to move into new therapeutic areas. We expect to see more partnerships of this kind, as the clinical trials landscape matures and achieves the scale to work with established organizations, like Privia.”